BCL2 and diffuse large B-cell lymphoma: BCL2 gene aberrations, other than t(14;18)(q32;q21), such as 18q21 amplification or activation of the nuclear factor-kB pathway, has been suggested to be the main responsible act for dysregulation of BCL2 protein expression in the DLBCL non-GCB subtype 34.